A phase I clinical trial evaluating the application of hydrogel in reducing rectal dose during cervical cancer brachytherapy

IF 2.7 3区 医学 Q3 ONCOLOGY
Yuxuan Wang , Hongnan Zhen , Ke Hu , Lang Yu , Jie Zhang , Chunli Luo , Lihua Yu , Junfang Yan , Fuquan Zhang
{"title":"A phase I clinical trial evaluating the application of hydrogel in reducing rectal dose during cervical cancer brachytherapy","authors":"Yuxuan Wang ,&nbsp;Hongnan Zhen ,&nbsp;Ke Hu ,&nbsp;Lang Yu ,&nbsp;Jie Zhang ,&nbsp;Chunli Luo ,&nbsp;Lihua Yu ,&nbsp;Junfang Yan ,&nbsp;Fuquan Zhang","doi":"10.1016/j.ctro.2024.100867","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>This study represents a prospective phase I clinical research to verify the effectiveness and reliability of hydrogel application in Chinese cervical cancer patients.</div></div><div><h3>Materials and Methods</h3><div>Eight patients were enrolled in the study. After completing intensity-modulated radiotherapy at 50.4 Gy/28 fractions, a 10 mL injection of hydrogel was administered to each patient through the posterior vaginal fornix under CT-guidance. Image-guided brachytherapy under CT or MRI guidance was given with a target dose of 6 Gy in 5 fractions to the high-risk clinical target volume. Rectal, sigmoid colon, and bladder D2cm3 were recorded for each brachytherapy. MRI scans were performed<!--> <!-->to measure the distance between the rectum and the cervix or tumor, as well as the spacer gel volume. Patients’ QLQ-C30 and QLQ-CX24 scores were recorded to assess treatment outcomes, and all adverse events were documented.</div></div><div><h3>Results</h3><div>Among the eight patients, the average D2cc was 60.9 ± 3.4 Gy for the rectum, 64.7 ± 6.8 Gy for sigmoid colon and 77.1 ± 7.4 Gy for bladder, respectively. The distance between the cervix and rectum significantly increased after gel injection. None of the eight patients experienced grade 3 or higher acute toxic reactions<!--> <!-->during brachytherapy. None patient<!--> <!-->experienced late rectal toxicity. No adverse events definitively associated with the hydrogel were observed. Patients’ subjective quality of life scores did not significantly change before and after gel injection. The reduction ro the volume of the hydrogel were observed during the 24 to 36 <!--> <!-->weeks after injection.</div></div><div><h3>Conclusion</h3><div>The application of the hydrogel effectively increased the distance between the cervix and rectum in brachytherapy for cervical cancer, limiting the rectal dose without increasing doses to other critical organs. In the short term, no severe adverse events were observed, indicating the safety and reliability of this approach. Further research is warranted to confirm its long-term safety and effectiveness.</div></div>","PeriodicalId":10342,"journal":{"name":"Clinical and Translational Radiation Oncology","volume":"49 ","pages":"Article 100867"},"PeriodicalIF":2.7000,"publicationDate":"2024-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405630824001447/pdfft?md5=ed484f6b876ea660f880efcfdaae59cb&pid=1-s2.0-S2405630824001447-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Translational Radiation Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405630824001447","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

This study represents a prospective phase I clinical research to verify the effectiveness and reliability of hydrogel application in Chinese cervical cancer patients.

Materials and Methods

Eight patients were enrolled in the study. After completing intensity-modulated radiotherapy at 50.4 Gy/28 fractions, a 10 mL injection of hydrogel was administered to each patient through the posterior vaginal fornix under CT-guidance. Image-guided brachytherapy under CT or MRI guidance was given with a target dose of 6 Gy in 5 fractions to the high-risk clinical target volume. Rectal, sigmoid colon, and bladder D2cm3 were recorded for each brachytherapy. MRI scans were performed to measure the distance between the rectum and the cervix or tumor, as well as the spacer gel volume. Patients’ QLQ-C30 and QLQ-CX24 scores were recorded to assess treatment outcomes, and all adverse events were documented.

Results

Among the eight patients, the average D2cc was 60.9 ± 3.4 Gy for the rectum, 64.7 ± 6.8 Gy for sigmoid colon and 77.1 ± 7.4 Gy for bladder, respectively. The distance between the cervix and rectum significantly increased after gel injection. None of the eight patients experienced grade 3 or higher acute toxic reactions during brachytherapy. None patient experienced late rectal toxicity. No adverse events definitively associated with the hydrogel were observed. Patients’ subjective quality of life scores did not significantly change before and after gel injection. The reduction ro the volume of the hydrogel were observed during the 24 to 36  weeks after injection.

Conclusion

The application of the hydrogel effectively increased the distance between the cervix and rectum in brachytherapy for cervical cancer, limiting the rectal dose without increasing doses to other critical organs. In the short term, no severe adverse events were observed, indicating the safety and reliability of this approach. Further research is warranted to confirm its long-term safety and effectiveness.
评估水凝胶在宫颈癌近距离治疗中减少直肠剂量应用的 I 期临床试验
目的 本研究是一项前瞻性 I 期临床研究,旨在验证水凝胶在中国宫颈癌患者中应用的有效性和可靠性。每位患者在完成 50.4 Gy/28 分次的调强放疗后,在 CT 引导下经阴道后穹窿注射 10 mL 水凝胶。在 CT 或 MRI 引导下,对高风险临床靶区进行了图像引导近距离放射治疗,目标剂量为 6 Gy,分 5 次进行。每次近距离治疗都记录了直肠、乙状结肠和膀胱的 D2cm3。磁共振成像扫描用于测量直肠与宫颈或肿瘤之间的距离以及间隔凝胶体积。记录患者的 QLQ-C30 和 QLQ-CX24 评分,以评估治疗效果,并记录所有不良事件。结果八名患者的直肠平均 D2cc 为 60.9 ± 3.4 Gy,乙状结肠为 64.7 ± 6.8 Gy,膀胱为 77.1 ± 7.4 Gy。注射凝胶后,宫颈和直肠之间的距离明显增加。八名患者在近距离治疗过程中均未出现 3 级或以上急性毒性反应。没有患者出现晚期直肠毒性反应。没有观察到与水凝胶明确相关的不良反应。注射凝胶前后,患者的主观生活质量评分没有明显变化。结论在宫颈癌近距离放射治疗中,水凝胶的应用有效地增加了宫颈与直肠之间的距离,限制了直肠的剂量,而不会增加其他重要器官的剂量。在短期内,没有观察到严重的不良反应,表明这种方法安全可靠。要确认其长期安全性和有效性,还需要进一步的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology Medicine-Radiology, Nuclear Medicine and Imaging
CiteScore
5.30
自引率
3.20%
发文量
114
审稿时长
40 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信